Description:
NSABP PROTOCOL B-35 Treatment of Ipsilateral or Contralateral Breast Event Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A019BB52-B911-3D6B-E034-080020C9C0E0
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A019BB52-B911-3D6B-E034-080020C9C0E0Keywords:
Versions (3)
- 8/26/12 8/26/12 -
- 7/8/15 7/8/15 -
- 7/8/15 7/8/15 -
Uploaded on:
August 26, 2012
DOI:
To request one please log in.License :
Creative Commons BY-NC 3.0 LegacyModel comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Breast Cancer NCT00053898 Treatment - NSABP PROTOCOL B-35 Treatment of Ipsilateral or Contralateral Breast Event - 2033836v3.0
Form T2 (04-30-2002) Submit this form to report treatment undertaken within 6 months of diagnosis of any invasive or non-invasive Ipsilateral Breast Tumor Recurrence (IBTR) or Cancer in Opposite Breast.
- StudyEvent: NSABP PROTOCOL B-35 Treatment of Ipsilateral or Contralateral Breast Event